pCRIS-PITChv2-FBL Citations (12)
Originally described in: MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems.Sakuma T, Nakade S, Sakane Y, Suzuki KT, Yamamoto T Nat Protoc. 2016 Jan;11(1):118-33. doi: 10.1038/nprot.2015.140. Epub 2015 Dec 17. PubMed Journal
Articles Citing pCRIS-PITChv2-FBL
| Articles |
|---|
| The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation. Long Q, Yan R, Hu J, Cai D, Mitra B, Kim ES, Marchetti A, Zhang H, Wang S, Liu Y, Huang A, Guo H. PLoS Pathog. 2017 Dec 29;13(12):e1006784. doi: 10.1371/journal.ppat.1006784. eCollection 2017 Dec. PubMed |
Microhomology based CRISPR tagging tools for protein tracking, purification, and depletion.
Lin DW, Chung BP, Huang JW, Wang X, Huang L, Kaiser P.
J Biol Chem. 2019 May 28. pii: RA119.008422. doi: 10.1074/jbc.RA119.008422.
PubMed
Associated Plasmids |
| An efficient gene knock-in strategy using 5'-modified double-stranded DNA donors with short homology arms. Yu Y, Guo Y, Tian Q, Lan Y, Yeh H, Zhang M, Tasan I, Jain S, Zhao H. Nat Chem Biol. 2020 Apr;16(4):387-390. doi: 10.1038/s41589-019-0432-1. Epub 2019 Dec 23. PubMed |
| Limited dishevelled/Axin oligomerization determines efficiency of Wnt/beta-catenin signal transduction. Kan W, Enos MD, Korkmazhan E, Muennich S, Chen DH, Gammons MV, Vasishtha M, Bienz M, Dunn AR, Skiniotis G, Weis WI. Elife. 2020 Apr 16;9. pii: 55015. doi: 10.7554/eLife.55015. PubMed |
| MITOL promotes cell survival by degrading Parkin during mitophagy. Shiiba I, Takeda K, Nagashima S, Ito N, Tokuyama T, Yamashita SI, Kanki T, Komatsu T, Urano Y, Fujikawa Y, Inatome R, Yanagi S. EMBO Rep. 2021 Mar 3;22(3):e49097. doi: 10.15252/embr.201949097. Epub 2021 Feb 10. PubMed |
| Four-dimensional nuclear speckle phase separation dynamics regulate proteostasis. Dion W, Ballance H, Lee J, Pan Y, Irfan S, Edwards C, Sun M, Zhang J, Zhang X, Liu S, Zhu B. Sci Adv. 2022 Jan 7;8(1):eabl4150. doi: 10.1126/sciadv.abl4150. Epub 2022 Jan 5. PubMed |
| An oncogenic splice variant of PDGFRalpha in adult glioblastoma as a therapeutic target for selective CDK4/6 inhibitors. Hamada T, Akahane T, Yokoyama S, Higa N, Kirishima M, Matsuo K, Shimokawa M, Yoshimoto K, Tanimoto A. Sci Rep. 2022 Jan 24;12(1):1275. doi: 10.1038/s41598-022-05391-9. PubMed |
| C9ORF78 partially localizes to centromeres and plays a role in chromosome segregation. Koranne R, Brown K, Vandenbroek H, Taylor WR. Exp Cell Res. 2022 Apr 15;413(2):113063. doi: 10.1016/j.yexcr.2022.113063. Epub 2022 Feb 12. PubMed |
| Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platforms. Grohmann C, Magtoto CM, Walker JR, Chua NK, Gabrielyan A, Hall M, Cobbold SA, Mieruszynski S, Brzozowski M, Simpson DS, Dong H, Dorizzi B, Jacobsen AV, Morrish E, Silke N, Murphy JM, Heath JK, Testa A, Maniaci C, Ciulli A, Lessene G, Silke J, Feltham R. Nat Commun. 2022 Apr 19;13(1):2073. doi: 10.1038/s41467-022-29670-1. PubMed |
| Differential cofactor dependencies define distinct types of human enhancers. Neumayr C, Haberle V, Serebreni L, Karner K, Hendy O, Boija A, Henninger JE, Li CH, Stejskal K, Lin G, Bergauer K, Pagani M, Rath M, Mechtler K, Arnold CD, Stark A. Nature. 2022 Jun;606(7913):406-413. doi: 10.1038/s41586-022-04779-x. Epub 2022 Jun 1. PubMed |
| Intrinsically disordered region-mediated condensation of IFN-inducible SCOTIN/SHISA-5 inhibits ER-to-Golgi vesicle transport. Kim N, Kim TH, Kim C, Lee JE, Kang MG, Shin S, Jung M, Kim JS, Mun JY, Rhee HW, Park SY, Shin Y, Yoo JY. Dev Cell. 2023 Oct 9;58(19):1950-1966.e8. doi: 10.1016/j.devcel.2023.08.030. PubMed |
| Comparison of Multiple Strategies for Precision Transgene Knock-In in Gallus gallus Genome via Microhomology-Mediated End Joining. Wang L, Sun J, Liu Z, Zheng Q, Wang G. Int J Mol Sci. 2023 Oct 29;24(21):15731. doi: 10.3390/ijms242115731. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.